InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration (iAMD) and diabetic retinal eye disease.
The trial evaluated ONS-5010 in wet age-related macular degeneration patients, and the company plans to resubmit a Biologics License Application in the first quarter of…
KOLOA, Hawaii — Faricimab helped improve vision in previously untreated patients with neovascular age-related macular degeneration, according to a real-world study presented at Retina 2025.…
Academy of Ophthalmology IRIS Registry (Intelligent Research in Sight). Multivariable Cox proportional hazards models were fit to examine the relationships between sociodemographic variables and time…
Positive efficacy and safety data were observed at 3 months after a single injection of K8 in this study conducted at the University of Kentucky.
KOLOA, Hawaii — Start with the patient’s chief complaint when making a differential diagnosis in uveitis, a retina specialist said at Retina 2025. “You see…
A 32-year-old highly myopic woman with macula-off detachment from a giant tear underwent vitrectomy with perfluorocarbon, and silicone oil. Postoperatively, vision was 20/200, with metamorphopsia…
In the first of a three-part series, William F. Wiley, MD, discusses the evolution of canaloplasty and its role in his cataract practice.
Retinal findings raised suspicion for this inherited retinal disease, confirmed with genetic testing.
With its approval in 2017, many physicians have several years of lessons learned with the Light Adjustable Lens (LAL, RxSight). With the more recent commercial…
